首页    期刊浏览 2025年02月26日 星期三
登录注册

文章基本信息

  • 标题:Cannabigerol and cannabichromene in Cannabis sativa L.
  • 本地全文:下载
  • 作者:Marjeta Zagožen ; Andreja Čerenak ; Samo Kreft
  • 期刊名称:Acta Pharmaceutica
  • 电子版ISSN:1846-9558
  • 出版年度:2021
  • 卷号:71
  • 期号:3
  • 页码:355-364
  • DOI:10.2478/acph-2021-0021
  • 语种:English
  • 出版社:Sciendo
  • 摘要:In addition to delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), other phytocannabinoids, such as cannabigerol (CBG) and cannabichromene (CBC), also have beneficial effects on human health. A high content of CBG is found in plants with the B0genotype, whereas CBC is independent of the allelic chemotype locus B. In basic research models such as mice or rats, CBG has demonstrated anticancer properties, particularly against breast cancer. CBG has shown anti-inflammatory effects on murine colitis and on inflammatory bowel disease as well as stimulatory effects on the feeding behaviors of mice. It has also exhibited inhibition of aldose reductase, which is known to cause an accumulation of sorbitol and increase glucose levels in the blood, which may lead to diabetes. Cannabinoid CBC has also shown anti-inflammatory effects and reduced hypermobility in the gut and has displayed potentialin vitroeffect on adult neural stem progenitor cells. CBC also exerts modest analgesic properties in rodents, as well as anti-fungal, anti-bacterial, pro-apoptotic, and anti-proliferative effects in tumor cells.
国家哲学社会科学文献中心版权所有